Although statistics are provided for one disease, BC can be classified into four molecular subtypes depending on the overexpression of three molecular markers: estrogen receptor (ER), progesterone receptor (PR), and Human Epidermal Receptor 2 (HER2) [1]. This evidence concerns the gene PGR and breast cancer.